Compositions and methods for monitoring breast cancer treatment

Details Compositions and methods for monitoring breast cancer treatment Compositions and methods for monitoring breast cancer treatment

2006-12-22

2009-10-13

Desai, Anand U (Department: 1656)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

C514S002600

Reexamination Certificate

active

07601800

ABSTRACT:
The present invention provides compositions and processes for preparing the same wherein the compositions are useful for monitoring breast cancer treatment.

REFERENCES:
patent: 5248697 (1993-09-01), Wilmore
patent: 5438075 (1995-08-01), Skubitz et al.
patent: 5576301 (1996-11-01), Hymer et al.
patent: 7186517 (2007-03-01), Suva et al.
patent: 2002/0147156 (2002-10-01), Petit, II et al.
patent: 2003/0099722 (2003-05-01), Baxter
patent: 2005/0042700 (2005-02-01), Suva et al.
patent: WO-2005/012904 (2005-02-01), None
Raida et al., “Liquid Chromatography and Electron Mass Spectrometric Mapping of Peptides from Human Plasma Filtrate”, J Am Soc Mass Spectrom 10: 45-54 (1999).
PCT Application No. PCT/US2004/024928, International Search Report and Written Opinion mailed Dec. 1, 2005, 14 pgs.
PCT Application No. PCT/US2004/024928, International Preliminary Report on Patentability mailed Feb. 6, 2006, 9 pgs.
U.S. Appl. No. 10/903,500, Notice of Allowance mailed Sep. 29, 2006, 9 pgs.
U.S. Appl. No. 10/903,500, Amendment and Response filed Jun. 14, 2006 to Non-Final Office Action mailed Mar. 8, 2006, 7 pgs.
U.S. Appl. No. 10/903,500, Non-Final Office Action mailed Mar. 8, 2006, 9 pgs.
U.S. Appl. No. 10/903,500, Response to Restriction Requirement mailed Dec. 8, 2005, 6 pgs.
U.S. Appl. No. 10/903,500, Restriction Requirement mailed Nov. 1, 2005, 6 pgs.
Burnet, N. G., et al., “Describing Patients' Normal Tissue Reactions: Concerning the Possibility of Individualising Radiotherapy Dose Prescriptions Based on Potential Predictive Assays of Normal Tissue Radiosensitivity”,Int. J. Cancer(Pred. Oncol.),79, (1998), 606-613.
Geara, F., et al., “Intrinsic Radiosensitivity of Normal Human Fibroblasts and Lymphocytes After High- and Low-Dose-Rate Irradiation”,Cancer Research,52, (Nov. 15, 1992), 6348-6352.
Hellman, S., et al., “Chapter 16—Principles of Cancer Management: Radiation Therapy”,Cancer, Principles and Practice of Oncology,Lippincott, Williams & Wilkins, Publishers (2001), 265-288.
Mattison, P., et al., “Serum Proteins as Tumor Markers for Breast Cancer”,British Journal of Cancer,43, (1981), 542-545.
Skubitz, K. M., et al., “Oral Glutamine to Prevent Chemotherapy Induced Stomatitis: A Pilot Study”,Journal of Laboratory&Clinical Medicine,127, (Feb. 1996), 223-228.

Affiliated with

Also associated with

Rating

Compositions and methods for monitoring breast cancer treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for monitoring breast cancer treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for monitoring breast cancer treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4110986